Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the stress-like and other aversive consequences of drug abuse, such as withdrawal from alcohol. Two CRH receptors, Crhr1 and Crhr2, have been identified in the mouse. Crhr1 is highly expressed in the anterior pituitary, neocortex, hippocampus, amygdala and cerebellum, and activation of this receptor stimulates adenylate cyclase. Here we show that in mice lacking Crhr1, the medulla of the adrenal gland is atrophied and stress-induced release of adrenocorticotropic hormone (ACTH) and corticosterone is reduced. The homozygous mutants exhibit increased exploratory activity and reduced anxiety-related behaviour under both basal conditions and following alcohol withdrawal. Our results demonstrate a key role of the Crhr1 receptor in mediating the stress response and anxiety-related behaviour.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, plasma corticosterone levels in Crhr1 KO mice were significantly less than those of WT mice after forced-swim stress (15).”
From Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation (2000) · cites this paper as [15]
In the citing paper
“CRF 1 overexpression results in an anxiogenic-and depressive-like profile in rodents and humans [342][343][344][345][346].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [343]
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946
Chalmers, D., Lovenberg, T., & De Souza, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 919
Gene Targeting: A Practical Approach
Hirst, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 585
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Swanson, L. W., & Simmons, D. M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902850402 · Cited by 478
Stenzel-Poore, M., Heinrichs, S., Rivest, S., Koob, G., & Vale, W. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02579.1994 · Cited by 468
Cited by
Items 201–300 of 1,000
Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors
Suda, T., Kageyama, K., Sakihara, S., & Nigawara, T. (2004) · Peptides · doi:10.1016/j.peptides.2004.03.027 · Cited by 114
Arborelius, L., Skelton, K. H., Thrivikraman, K. V., Plotsky, P. M., Schulz, D. W., & Owens, M. J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39110-4 · Cited by 101
“Studies using CRF1 receptor knockout mice and CRF1 and CRF2 receptor antisense oligonucleotides have revealed that the anxiogenic effect of CRF appears to be mediated by the CRF1 receptor subtype (Heinrichs et al., 1997; Smith et al., 1998; Timpl et al., 1998).”
BackgroundKinlein, S. A., & Karatsoreos, I. N. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100819 · Cited by 115
Million, M., Grigoriadis, D. E., Sullivan, S., Crowe, P. D., McRoberts, J. A., Zhou, H., Saunders, P. R., Maillot, C., Mayer, E. A., & Taché, Y. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03027-0 · Cited by 113
Martin-Fardon, R., Zorrilla, E. P., Ciccocioppo, R., & Weiss, F. (2010) · Brain Research · doi:10.1016/j.brainres.2009.12.027 · Cited by 112
“Systemic administration of selective CRF1 antagonists or CRF1 deletion effectively reduces anxiety-like behavior during acute ethanol withdrawal, revealing a role for the CRF1 receptor in these adaptations (Breese et al., 2004; Knapp et al., 2004; Overstreet et al., 2004; Timpl et al., 1998).”
Neuroendocrine pathways of addictive behaviour
F, K., & K, W. (2004) · Addiction Biology · doi:10.1080/13556210412331292532 · Cited by 107
Matys, T., Pawlak, R., Matys, E., Pavlides, C., McEwen, B. S., & Strickland, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407355101 · Cited by 111
Regev, L., Neufeld-Cohen, A., Tsoory, M., Kuperman, Y., Getselter, D., Gil, S., & Chen, A. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.64 · Cited by 110
Sillaber, I., Panhuysen, M., Henniger, M. S. H., Ohl, F., Kühne, C., Pütz, B., Pohl, T., Deussing, J. M., Paez-Pereda, M., & Holsboer, F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1232-6 · Cited by 93
Self-citationCRH, Stress, and Major Depression: A Psychobiological Interplay
Claes, S. J. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)69005-4 · Cited by 108
Funk, C. K., & Koob, G. F. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.009 · Cited by 109
“CRF1 receptors are located throughout the brain (Van Pett et al., 2000) and play an important role in mediating anxietylike behavior (Liebsch et al., 1995, 1999; Heinrichs et al., 1997; Smith et al., 1998; Timpl et al., 1998; Muller et al., 2003; Zorrilla and Koob, 2004).”
BackgroundA triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery
Neufeld-Cohen, A., Tsoory, M. M., Evans, A. K., Getselter, D., Gil, S., Lowry, C. A., Vale, W. W., & Chen, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013761107 · Cited by 96
“CRFR1KO mice display decreased anxiety-like behaviors coupled with an impaired HPA axis stress response (16, 17), whereas CRFR2KOmice show increased anxiety-like behaviors and an accelerated HPA-axis response to stress (18, 19).”
BackgroundSabino, V., Cottone, P., Koob, G. F., Steardo, L., Lee, M. J., Rice, K. C., & Zorrilla, E. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0546-5 · Cited by 108
Galanin, Galanin Receptor Subtypes and Depression-Like Behaviour
Kuteeva, E., Hökfelt, T. G. M., Wardi, T., & Ögren, S. O. (2010) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0346-0228-0_12 · Cited by 106
CRF signaling: molecular specificity for drug targeting in the CNS
ARZT, E. S., & Holsboer, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.007 · Cited by 106
Self-citationGutman, D. A., Owens, M. J., Skelton, K. H., Thrivikraman, K. V., & Nemeroff, C. B. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042788 · Cited by 106
“…mediate the anxiogenic affects of CRF. CRF1 receptor knockout mice exhibit a reduced stress response, whereas CRF2 receptor knockout mice seemed to be more anxious than controls (Timpl et al., 1998; Bale et al., 2000; Kishimoto et al., 2000), although this view is by no means universal.”
BackgroundChen, A. M., Perrin, M. H., DiGruccio, M. R., Vaughan, J. M., Brar, B. K., Arias, C. M., Lewis, K. A., Rivier, J. E., Sawchenko, P. E., & Vale, W. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409583102 · Cited by 92
Zuloaga, D. G., Heck, A. L., De Guzman, R. M., & Handa, R. J. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00319-2 · Cited by 90
On the role of corticotropin-releasing hormone receptors in anxiety and depression
Reul, J. M. H. M., & Holsboer, F. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.1/jreul · Cited by 103
Self-citationKolber, B. J., Boyle, M. P., Wieczorek, L., Kelley, C. L., Onwuzurike, C. C., Nettles, S. A., Vogt, S. K., & Muglia, L. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4470-09.2010 · Cited by 95
Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety
Keck, M. E. (2006) · Amino Acids · doi:10.1007/s00726-006-0333-y · Cited by 102
“The behavioral analyses of CRF1 null mutants, however, are hampered by the fact that CRF1 knockout mice display severe glucocorticoid deficiency (Smith et al., 1998; Timpl et al., 1998).”
BackgroundInfluentialBehavioral responses to stress are intact in CRF-deficient mice
Dunn, A. J., & Swiergiel, A. H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01912-5 · Cited by 102
MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist
RICHARDSON, H., ZHAO, Y., Fekete, É. M., FUNK, C., Wirsching, P., Janda, K. D., Zorrilla, E. P., & Koob, G. F. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.10.008 · Cited by 101
“Genetic and pharmacological evidence implicates CRF1 in mediating anxiety-related behaviors in animals (Timpl et al., 1998; Smith et al., 1998; Heinrichs et al., 1997; Liebsch et al., 1995; McElroy et al., 2002; Zorrilla et al., 2002, 2003).”
BackgroundRole of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats
Martínez, V., & Taché, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03277-7 · Cited by 101
Tau's role in the developing brain: implications for intellectual disability
Sapir, T., Frotscher, M., Levy, T., Mandelkow, E.-M., & Reiner, O. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr603 · Cited by 89
Class II G Protein-Coupled Receptors and Their Ligands in Neuronal Function and Protection
Martin, B., de Maturana, R. L., Brenneman, R., Walent, T., Mattson, M. P., & Maudsley, S. R. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:003 · Cited by 99
“Transgenic mice deficient in CRHR1 have been shown to exhibit impaired stress responses and reduced anxiety due to an improperly developed HPA axis (Smith et al., 1998; Timpl et al., 1998).”
BackgroundMice with Mutations in the HPA-System as Models for Symptoms of Depression
Müller, M. B., & Holsboer, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.008 · Cited by 99
Self-citationBehavioral Neurobiology of Alcohol Addiction
Sommer, W. H., & Spanagel, R. (2012) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-28720-6 · Cited by 99
Self-citationThe Molecular Pathogenesis of Corticotroph Tumors
Dahia, P. L. M., & Grossman, A. B. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.2.0358 · Cited by 99
Chen, A., Perrin, M., Brar, B., Li, C., Jamieson, P., DiGruccio, M., Lewis, K., & Vale, W. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0300 · Cited by 86
MOLECULAR EVOLUTION OF GPCRS: Melanocortin/melanocortin receptors
Dores, R. M., Londraville, R. L., Prokop, J., Davis, P., Dewey, N., & Lesinski, N. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0050 · Cited by 92
Rabeler, R., Mittag, J., Geffers, L., Rüther, U., Leitges, M., Parlow, A. F., Visser, T. J., & Bauer, K. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0017 · Cited by 91
Nijsen, M., Croiset, G., Stam, R., Bruijnzeel, A., Diamant, M., de Wied, D., & Wiegant, V. M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00126-8 · Cited by 98
“…show that CRH type 1 but not type 2 receptor knockdown produces anxiolytic-like behavioral effects, and reduces plasma adrenocorticotropic hormone (ACTH) and corticosterone (CS) levels under both basal and stressful conditions in mice (Heinrichs et al. 1997, Smith et al. 1998, Timpl et al. 1998).”
BackgroundMouse models for psychiatric disorders
Seong, E., Seasholtz, A. F., & Burmeister, M. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02807-x · Cited by 98
WEBSTER, E. L., Barrientos, R. M., Contoreggi, C. S., Isaac, M. G., Ligier, S., Gabry, K. E., Chrousos, G. P., McCarthy, E. F., Rice, K. C., Gold, P. W., et al. (2002) · PubMed · Cited by 97
Millan, M. J., Brocco, M., Gobert, A., Dorey, G., Casara, P., & Dekeyne, A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00244-5 · Cited by 97
“Third, underpinning these observations, CRF 1 receptor-deficient mice display reduced anxiety in a variety of experimental paradigms (Timpl et al. 1998; Contarino et al. 1999; see also Steckler and Holsboer 1999).”
BackgroundA robust and reliable non-invasive test for stress responsivity in mice
Zimprich, A., Garrett, L., Deussing, J. M., Wotjak, C. T., Fuchs, H., Gailus-Durner, V., de Angelis, M. H., Wurst, W., & Hölter, S. M. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00125 · Cited by 85
“Frontiers in Behavioral Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 125 | 2 CRHR1 knockout mouse line The corticotropin-releasing hormone receptor type 1 knockout (CRHR1-KO) mice were generated as previously described (for detailed description see Timpl et al., 1998).”
BackgroundMethodSelf-citationNew alcohol-related genes suggest shared genetic mechanisms with neuropsychiatric disorders
Εvangelou, Ε., Gao, H., Chu, C., Ntritsos, G., Blakeley, P., Butts, A. R., Pazoki, R., Suzuki, H., Koskeridis, F., Yiorkas, A. M., et al. (2019) · Nature Human Behaviour · doi:10.1038/s41562-019-0653-z · Cited by 95
Harris, R. B. S., Palmondon, J., Leshin, S., Flatt, W. P., & Richard, D. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.12.001 · Cited by 95
“…upon activation of CRF-R2 (Cullen et al., 2001), whereas stimulation of thermogenesis (Cullen et al., 2001), activation of the hypothalamic–pituitary adrenal axis (Pelleymounter et al., 2004; Timpl et al., 1998) and anxiety-type behavior (Contarino et al., 1999) may be dependent upon CRF-R1.”
BackgroundHolmes, K. D., Babwah, A. V., Dale, L. B., Poulter, M. O., & Ferguson, S. S. G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03603.x · Cited by 83
“…is expressed primarily in the brain and pituitary, and several pharmacological and genetic studies in mice have linked CRF1 receptor signaling to both anxiety and depressive disorders (Stenzel-Poore et al. 1994; Smith et al. 1998; Timpl et al. 1998; Okuyama et al. 1999; Smagin and Dunn 2000).”
BackgroundGetting closer to affective disorders: the role of CRH receptor systems
Müller, M. B., & Wurst, W. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.007 · Cited by 94
Self-citationBRADBURY, M. J., McBurnie, M. I., Denton, D. A., Lee, K., & Vale, W. (2000) · Endocrinology · doi:10.1210/en.141.8.2715 · Cited by 91
Regev, L., Tsoory, M., Gil, S., & Chen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.036 · Cited by 93
Evidence for the role of corticotropin-releasing factor in major depressive disorder
Waters, R. P., Rivalan, M., Bangasser, D. A., Deussing, J. M., Ising, M., Wood, S. K., Holsboer, F., & Summers, C. H. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.011 · Cited by 93
“In addition, the two independently generated CRF1-deficient mouse lines show a clear decrease in anxiety-related behaviors in various test paradigms compared to wild-type littermates (Smith et al., 1998; Timpl et al., 1998).”
BackgroundSelf-citationCorticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior
Fox, J. H., & Lowry, C. A. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00169 · Cited by 93
Spina, M. G., Pich, E. M., Akwa, Y., Balducci, C., Basso, A., Zorrilla, E. P., Britton, K. T., Rivier, J., Vale, W., & Koob, G. F. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0940-y · Cited by 93
Corticotropin-Releasing Hormone System in Human Adipose Tissue
Seres, J., Bornstein, S. R., Seres, P., Willenberg, H. S., Schulte, K. M., Scherbaum, W. A., & Ehrhart-Bornstein, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031299 · Cited by 86
McCrimmon, R. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27775 · Cited by 87
Neuroendocrine interactions of the stress and reproductive axes
Phumsatitpong, C., Wagenmaker, E. R., & Moenter, S. M. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100928 · Cited by 75
Neuronal actions of glucocorticoids: Focus on depression
Yu, S., Holsboer, F., & Almeida, O. F. X. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.014 · Cited by 91
Self-citationWiedemann, K., Jahn, H., Yassouridis, A., & Kellner, M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.371 · Cited by 84
Merali, Z., Khan, S., Michaud, D. S., Shippy, S. A., & Anisman, H. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03468.x · Cited by 82
“Inasmuch as CRH1-deficient mice exhibit diminished anxiety (Smith et al., 1998; Timpl et al., 1998) and CRH antagonists reduce anxiety associated with certain stressors (Deak et al., 1999; Habib et al., 2000; Keck et al., 2001), it was suggested that CRH1 receptors contribute to stressor-related…”
BackgroundDe Groote, L., Peñalva, R. G., Flachskamm, C., Reul, J. M. H. M., & Linthorst, A. C. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03164.x · Cited by 84
Self-citationPsychological co-morbidities in COPD: Targeting systemic inflammation, a benefit for both?
Pelgrim, C. E., Peterson, J. D., Gosker, H. R., Schols, A. M. W. J., van Helvoort, A., Garssen, J., Folkerts, G., & Kraneveld, A. D. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.001 · Cited by 90
Contet, C., Gavériaux‐Ruff, C., Matifas, A., Caradec, C., Champy, M., & Kieffer, B. L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300934 · Cited by 89
“The 10-min interval between the end of stress and the time of killing was chosen according to previous articles reporting simultaneous dosage of plasma ACTH and corticosterone (Timpl et al, 1998).”
Jamieson, P. M., Li, C., Kukura, C., Vaughan, J., & Vale, W. (2006) · Endocrinology · doi:10.1210/en.2006-0545 · Cited by 83
Basic Pathophysiologic Mechanisms in Irritable Bowel Syndrome
Mayer, E. A., Naliboff, B. D., & Chang, L. (2001) · Digestive Diseases · doi:10.1159/000050682 · Cited by 80
Ho, S. P., Takahashi, L. K., Livanov, V., Spencer, K. R., Lesher, T., Maciag, C. M., Smith, M. A., Rohrbach, K. W., Hartig, P. R., & Arnerić, S. P. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00050-x · Cited by 89
Richter, R. M., Zorrilla, E. P., Basso, A. M., Koob, G. F., & Weiss, F. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200012000-00004 · Cited by 82
Ishitobi, Y., Nakayama, S., Yamaguchi, K., Kanehisa, M., Higuma, H., Maruyama, Y., Ninomiya, T., Okamoto, S., Tanaka, Y., Tsuru, J., et al. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32046 · Cited by 77
“ACTH and cortisol responsiveness to CRF after dexamethasone are markedly increased in MDD patients compared to healthy control subjects [Isogawa et al., 2005].”
BackgroundInfluentialChen, A., Blount, A., Vaughan, J., Brar, B., & Vale, W. (2004) · Endocrinology · doi:10.1210/en.2003-1570 · Cited by 76
Endocrinology and the brain: corticotropin-releasing hormone signaling
Inda, C., Armando, N. G., Claro, P. A. D. S., & Silberstein, S. (2017) · Endocrine Connections · doi:10.1530/ec-17-0111 · Cited by 89
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice
Nielsen, D. M., Carey, G. J., & Gold, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.091 · Cited by 87
Tezval, H., Jahn, O., Todorovic, C., Sasse, A., Eckart, K., & Spiess, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403159101 · Cited by 80
Gragnoli, C. (2014) · The Application of Clinical Genetics · doi:10.2147/tacg.s39993 · Cited by 72
Chen, C., & Fernald, R. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020313 · Cited by 86
Howerton, A. R., Roland, A. V., Fluharty, J. M., Marshall, A., Chen, A., Daniels, D., Beck, S. G., & Bale, T. L. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.013 · Cited by 80
Bale, T. L., Anderson, K. R., Roberts, A. J., Lee, K.-F., Nagy, T. R., & Vale, W. W. (2003) · Endocrinology · doi:10.1210/en.2002-0091 · Cited by 83
Neeck, G. (2000) · Scandinavian Journal of Rheumatology · doi:10.1080/030097400446562 · Cited by 75
“(37) have recently demonstrated that a lack of CRH-1 receptors (CRHr1) in speci®c areas of the brain drastically reduces the physiological responses to stress as well as the related anxiety reaction.”
BackgroundBrunson, K. L., Grigoriadis, D. E., Lorang, M. T., & Baram, T. Z. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7937 · Cited by 85
Rutherford, K., Piastowska‐Ciesielska, A. W., Donald, R. D., Robson, S. K., Ison, S. H., Jarvis, S., Brunton, P. J., Russell, J. A., & Lawrence, A. B. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.02.052 · Cited by 84
“have shown that CRH-R1 gene deletion reduces anxious behaviour and attenuates peripheral stress responses [30, 35], whereas CRH-R2 knockouts show increased stress responsiveness [36].”
BackgroundTodorovic, C., Sherrin, T., Pitts, M., Hippel, C., Rayner, M., & Spiess, J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.178 · Cited by 76
Maternal High-fat Diet Programs Offspring Emotional Behavior in Adulthood
Winther, G., Elfving, B., Müller, H. K., Lund, S., & Wegener, G. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.014 · Cited by 75
ACTH-induced Nucleocytoplasmic Translocation of Salt-inducible Kinase
Takemori, H., Katoh, Y., Horike, N., Doi, J., & Okamoto, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204602200 · Cited by 84
Grigoriadis, D. E. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.651 · Cited by 75
“CRF seems to play a major role in the maintenance of cocaine self-administration, and CRF1 receptor antagonists block stress-induced reinstatement of cocaine/heroin use [313-318]”
BackgroundKarpac, J., Ostwald, D., Bui, S., Hunnewell, P., Shankar, M., & Hochgeschwender, U. (2005) · Endocrinology · doi:10.1210/en.2004-1290 · Cited by 74
Wang, X., Su, H., Copenhagen, L. D., Vaishnav, S., Pieri, F., Shope, C. D., Brownell, W. E., De Biasi, M., Paylor, R., & Bradley, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6605-6610.2002 · Cited by 76
Genetic insights into the neurobiology of anxiety
Koskinen, M.-K., & Hovatta, I. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.01.007 · Cited by 83
Fan, J., Chen, X.-Q., Jin, H., & Du, J.-Z. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.009 · Cited by 82
Spiga, F., Lightman, S. L., Shekhar, A., & Lowry, C. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.051 · Cited by 82
Central corticotropin releasing factor and social stress
Bäckström, T., & Winberg, S. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00117 · Cited by 82
“The CRF-R1 have been reported to mediate the activation of the HPA/HPI axis (Timpl et al., 1998; Bale et al., 2002b; Huising et al., 2004) and to induce anxiety-like behavior (Britton et al., 1986; Heinrichs et al., 1997; Bale et al., 2002b), whereas the CRF-R2 have been reported to affect several…”
Haass-Koffler, C. L., & Bartlett, S. E. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00091 · Cited by 71
“PKCε signaling pathway in the CeA is activated by CRF-R1 activation and modulates GABAergic neurotransmission that may contribute to the anxiogenic effects of ethanol (Smith et al., 1998; Timpl et al., 1998).”
BackgroundPermutation-validated principal components analysis of microarray data
Landgrebe, J., Wurst, W., & Welzl, G. (2002) · Genome Biology · doi:10.1186/gb-2002-3-4-research0019 · Cited by 73
Self-citationAssociation of HPA axis genes with suicidal behaviour in schizophrenia
De Luca, V., Tharmalingam, S., Zai, C., Potapova, N., Strauss, J., Vincent, J., & Kennedy, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881108097817 · Cited by 75
Stress-induced priming of glutamate synapses unmasks associative short-term plasticity
Kuzmiski, J. B., Marty, V. N., Baimoukhametova, D. V., & Bains, J. S. (2010) · Nature Neuroscience · doi:10.1038/nn.2629 · Cited by 81
Catalano, R. D., Kyriakou, T., Chen, J., Easton, A., & Hillhouse, E. W. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0302 · Cited by 76
Teli, T., Markovic, D., Levine, M. A., Hillhouse, E. W., & Grammatopoulos, D. K. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0275 · Cited by 71
Arginine vasopressin: Direct and indirect action on metabolism
Yoshimura, M., Conway-Campbell, B. L., & Ueta, Y. (2021) · Peptides · doi:10.1016/j.peptides.2021.170555 · Cited by 79
Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission
Vannucchi, M. G., & Evangelista, S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7010004 · Cited by 79
Deciphering sex differences in the immune system and depression
Rainville, J. R., Tsyglakova, M., & Hodes, G. E. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.12.004 · Cited by 72
Schüle, C., Baghai, T. C., Eser, D., & Rupprecht, R. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.52 · Cited by 73
Chen, A. C. H., Manz, N., Tang, Y., Rangaswamy, M., Almasy, L., Kuperman, S., Nurnberger, J., O’Connor, S. J., Edenberg, H. J., Schuckit, M. A., et al. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01173.x · Cited by 68
“In the Crhr1knockout mouse model, mice lacking the Crhr1 receptor, but not the highly homologous Crhr2 receptor, exhibited impaired stress response and reduced anxiety under basal conditions and during alcohol withdrawal (Timpl et al., 1998).”
BackgroundGalanin Receptor Antagonists: A Potential Novel Pharmacological Treatment for Mood Disorders
Ögren, S. O., Kuteeva, E., kfelt, T. H., & Kehr, J. (2006) · CNS Drugs · doi:10.2165/00023210-200620080-00003 · Cited by 78
Million, M., Wang, L., Martínez, V., & Taché, Y. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02719-0 · Cited by 78
KO's and organisation of peptidergic feeding behavior mechanisms
Beck, B. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00003-3 · Cited by 78
Anisman, H., Merali, Z., & Stead, J. D. H. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.001 · Cited by 77
CRH Signaling: Molecular Specificity for Drug Targeting in the CNS
Refojo, D., & Holsboer, F. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04983.x · Cited by 65
Self-citationCRH Deficiency Impairs but Does Not Block Pituitary-Adrenal Responses to Diverse Stressors
Jacobson, L., Muglia, L. J., Weninger, S. C., Pacák, K., & Majzoub, J. A. (2000) · Neuroendocrinology · doi:10.1159/000054524 · Cited by 76
Normal Physiology of Hypothalamic Pituitary Regulation
Sam, S., & Frohman, L. A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.007 · Cited by 76
“expressed on corticotropes, which signals through cAMP [23,61,66,67].”
BackgroundPantazopoulos, H., Wiseman, J. T., Markota, M., Ehrenfeld, L., & Berretta, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.006 · Cited by 76
Metadata
- Authors
- Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Helmholtz Munich (DE)
- Corresponding author
- Wurst, Wolfgang
- Venue
- Nature Genetics
- Published
- 1998-06
- Volume
- 19
- Issue
- 2
- Pages
- 162-166
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/520
- OpenAlex
- W1572525448
- Semantic Scholar
- 963e2500bc129b9bfedf1ae198ec17a73626fcdc
- Cited by
- 919
- References
- 32
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 6 · 2022: 14 · 2021: 16 · 2020: 9 · 2019: 20 · 2018: 23 · 2017: 20 · 2016: 27 · 2015: 24 · 2014: 31 · 2013: 27 · 2012: 47
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Site cant be reached (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- corticotropin-releasing hormone receptor 1, stress response, anxiety-like behavior, ACTH, corticosterone, alcohol withdrawal, exploratory activity, CRH receptor 2, adenylate cyclase
- MeSH terms
- CRF Receptor, Type 1, Adrenocorticotropic Hormone, Ethanol, Animals, Anxiety, Cells, Cultured, Corticosterone, Pituitary Gland, Stress, Physiological, Substance Withdrawal Syndrome, In Situ Hybridization, Receptors, Corticotropin-Releasing Hormone, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.